Format

Send to

Choose Destination
See comment in PubMed Commons below
Stroke. 2014 Aug;45(8):2292-7. doi: 10.1161/STROKEAHA.114.005784. Epub 2014 Jul 3.

Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke.

Author information

1
From the Department of Neurology (B.B.N., A.E.M., N.T.C., H.K., C.I., L.M.D.) and Feil Family Brain and Mind Research Institute (B.B.N., H.K., C.I.), Weill Cornell Medical College, New York, NY; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY (B.B.N., S.S., J.B.S., L.M.D.); and Department of Neurology, College of Physicians and Surgeons and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY (M.S.V.E.). ban9003@med.cornell.edu.
2
From the Department of Neurology (B.B.N., A.E.M., N.T.C., H.K., C.I., L.M.D.) and Feil Family Brain and Mind Research Institute (B.B.N., H.K., C.I.), Weill Cornell Medical College, New York, NY; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY (B.B.N., S.S., J.B.S., L.M.D.); and Department of Neurology, College of Physicians and Surgeons and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY (M.S.V.E.).

Abstract

BACKGROUND AND PURPOSE:

Cryptogenic stroke is common in patients with cancer. Autopsy studies suggest that many of these cases may be because of marantic endocarditis, which is closely linked to cancer activity. We, therefore, hypothesized that among patients with cancer and ischemic stroke, those with cryptogenic stroke would have shorter survival.

METHODS:

We retrospectively analyzed all adult patients with active systemic cancer diagnosed with acute ischemic stroke at a tertiary care cancer center from 2005 through 2009. Two neurologists determined stroke mechanisms by consensus. Patients were diagnosed with cryptogenic stroke if no specific mechanism could be determined. The diagnosis of marantic endocarditis was restricted to patients with cardiac vegetations on echocardiography or autopsy and negative blood cultures. Patients were followed until July 31, 2012, for the primary outcome of death. Kaplan-Meier statistics and the log-rank test were used to compare survival between patients with cryptogenic stroke and patients with known stroke mechanisms. Multivariate Cox proportional hazard analysis evaluated the association between cryptogenic stroke and death after adjusting for potential confounders.

RESULTS:

Among 263 patients with cancer and ischemic stroke, 133 (51%) were cryptogenic. Median survival in patients with cryptogenic stroke was 55 days (interquartile range, 21-240) versus 147 days (interquartile range, 33-735) in patients with known stroke mechanisms (P<0.01). Cryptogenic stroke was independently associated with death (hazard ratio, 1.64; 95% confidence interval, 1.25-2.14) after adjusting for age, systemic metastases, adenocarcinoma histology, and functional status.

CONCLUSIONS:

Cryptogenic stroke is independently associated with reduced survival in patients with active cancer and ischemic stroke.

KEYWORDS:

endocarditis, non-infective; mortality; survival

PMID:
24994717
PMCID:
PMC4254829
DOI:
10.1161/STROKEAHA.114.005784
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center